← Leaderboards
Jack D Burton
Ctr For Molecular Medicine/Immunology
$775,259
Attributed
$775,259
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $211K · FY2006–07$250K$187.5K$125K$62.5K$0
'06
'07
Funding mix
By agency
NIH$775,259 · 4
By mechanism
R21$674,259 · 2
R03$101,000 · 1
P01$0 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHematopoietic Stem CellsClinical Trial Phase ISeleniumNeoplasm /Cancer Classification /StagingCircadian RhythmsHuman Therapy EvaluationHuman SubjectNeoplasm /Cancer ImmunotherapyYttriumNeoplasm /Cancer Radionuclide TherapyMonoclonal AntibodyDrug Screening /EvaluationBloodBioperiodicityAntineoplasticsBiological MarkersBiodistributionAntineoplastic AgentsAdenocarcinomaCancer PreventionCancerousCancer TherapyAttention
Grant awards (5)
Chronochemoprevention of Prostate Cancer$170,745
R21 · FY2007 · CA · contact PI
Chronochemoprevention of Prostate Cancer$211,014
R21 · FY2006 · CA · contact PI
Chronobiological Principles to Maximize Efficacy of Alt*$292,500
R21 · FY2004 · CA
RADIOIMMUNOTHERAPY OF EXTENSIVE STAGE SCLC$101,000
R03 · FY2000 · CA
RADIOIMMUNOTHERAPY OF STAGE IV BREAST CANCER$0
P01 · FY2000 · CA